Please login to the form below

Is fear an effective driver of behaviour change?

Client Lead Natalie Seebeck explains that applying fear-based models in communications can be effective, if the right components are used in the right way.
Since the mid-1950s, fear appeals have been applied in an effort to reduce a number of risky, yet modifiable, health related behaviours.¹ Today, they still remain a popular technique for creative agencies, researchers, interventionists, and policy makers.² Even influential bodies such as the World Health Organisation argue in favour of one of the best-illustrated examples of fear appeals; the health warnings on cigarette packages.³ However, if you ask a smoker about the warnings, you’ll often hear “I just ignore the warnings”, or “that’s not me so why would it affect me”.

So, can fear really motivate someone to change their behavior? Can it make a healthcare professional (HCP) choose one treatment over the other? Can it make a patient more adherent to their treatment or encourage them to exercise more, or change their diet? Can it make an HCP prescribe a treatment sooner rather than later?

Despite caution from some researchers, Client Lead Natalie Seebeck explains that applying fear-based models, specifically Protection Motivation Theory (PMT) and the Extended Parallel Processing Model (EPPM), in communications can be effective, if the right components are used in the right way. 

What is a ‘fear appeal’, and how does it work?

According to widely adopted fear appeal theories, such as PMT and EPPM, fear appeals are persuasive communications that consist of two key components:
  1. the presentation of a threat to an individual’s well-being that induces fear
  2. the presentation of recommendations, such as steps to avoid the threat or reduce the impact of the threat.⁴
Once these are presented, an individual’s evaluation or appraisal of these components is expected to result in a motivation to change behaviour.

Protection Motivation Theory: Weighing the threat against the cost of prevention

PMT, or Protection Motivation Theory, says that a change response is the result of two integrated appraisal processes: firstly a threat appraisal, followed by a coping appraisal.⁵
  1. A threat appraisal is the process whereby an individual compares the perceived severity of a threat and their personal likelihood of the worst case outcome, against the potential rewards of engaging in the risky behaviour.
  2. A coping appraisal is the process whereby an individual compares the efficacy of the recommended “self-protective” behaviour and the ease and confidence of executing that behavior, against the costs of choosing that risk reducing behaviour.⁵
The theory states that if the coping appraisal outweighs the threat appraisal, the individual will be motivated and implement the recommended “self-protective” behaviour.⁵For example:
  • Liz, who knows she has a high risk for skin cancer due to family history and skin type, will be more likely to apply sun cream (provided it is easy for them to access, and relatively cheap to purchase).
  • Leo, who knows he has a lower risk of skin cancer, or for whom the cost or convenience of applying sun cream is much higher, will probably forego it.
 References:
  1.  Floyd, Prentice-Dunn, and Rogers, 2000
  2.  Ruiter, Kessels, Peters, and Kok, 2014
  3.  Fong, Hammond, and Hitchman, 2009
  4.  Rogers, 1975; Witte, 1992
  5.  Rogers, 1975

Download the full article with PMT and EPPM models from Blue Latitude Health

1st February 2017

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Three strategies for managing loss of exclusivity successfully
Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
What does the future hold for Medical Affairs?
Lori Lush, Head of Fishawack Medical, reveals why she’s driven to tell impactful scientific stories, the benefits of cross-functional collaboration, and the trends she predicts for the next five years.
Blue Latitude Health
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences industry can do to rebuild trust.
Blue Latitude Health
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and Senior Consultant Craig Moore explore the benefits of using real-world evidence and the common pitfalls life science companies should avoid.
Blue Latitude Health
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of this lost time for patients?
Blue Latitude Health
Unpacking rare diseases in the first edition of Delta magazine
Fishawack Health launches Delta magazine with a deep dive into rare disease commercialization
Blue Latitude Health